April 30, 2026

Major insurers are standardizing electronic prior authorization processes across commercial, Medicare, and Medicaid plans to reduce paperwork and speed up care approvals for common services like imaging and surgeries. Industry groups say this will make submissions more consistent and efficient, with some insurers already standardizing a large share of requests and planning further expansion. However, the effort is voluntary, and critics note it lacks enforceable targets and doesn’t fully resolve ongoing delays or include all areas like prescription drugs.

Bipartisan lawmakers in the U.S. House of Representatives introduced the Medicare Advantage Improvement Act of 2026 to improve oversight of Medicare Advantage plans by increasing transparency, simplifying prior authorization, and reducing delays in care. The legislation also seeks to better align Medicare Advantage coverage with traditional Medicare, ease administrative requirements, and expand access to post-acute services, and it has received support from healthcare providers and program reform advocates.

Humana said declining enrollment in 4+ star plans could hurt 2026 quality bonus payments and margins, while higher-acuity new MA members and medical cost trend continue to pressure profitability even as the company plans more targeted benefit changes for 2027 bids.

Hospital consolidation has contributed to rising costs, and while hospitals do carry higher administrative burdens and tend to serve sicker populations compared to ASCs or outpatient facilities, the significant price gap for identical services remains difficult to justify. The willingness of major health system CEOs to come to the table on site-neutral reform suggests the industry recognizes that some recalibration is inevitable.

This announcement suggests that Cigna views the post-subsidy ACA market as increasingly unattractive and is choosing to redeploy attention toward businesses where it sees stronger strategic fit and more sustainable growth. This may not be a just a company-specific move, but part of a broader concern that the individual market could shrink as subsidy changes raise premiums and worsen selection.